NFE2L2 and non-small cell lung carcinoma: Most of the NRF2-positive cases, which are regarded as NRF2-activated cancers, were NOTCH3-positive (Fig. 2c), which was again consistent with our observation that NOTCH3 is a downstream effector of NRF2 in NRF2-activated NSCLC cell lines.